Healthy volunteers help unlock lung protein secrets for future PAH treatments
NCT ID NCT07362290
First seen Jan 31, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study involves 16 healthy volunteers to learn how a drug called XBD173 binds to a protein (TSPO) in the lungs. Researchers will use PET scans and blood tests to find the right dose and understand how food affects the drug. The goal is to gather knowledge for designing future studies on pulmonary hypertension.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS - MALE AND FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NIHR Imperial CRF
London, W12 0HS, United Kingdom
Conditions
Explore the condition pages connected to this study.